Exclusive Interview with CB2Insights Co-Founder and CEO Prad Sekar
CB2 Insights (CSE: CBII) (OTC: CBIIF) is using data and proprietary technology to drive the integration of medical cannabis into traditional clinical practice. Co-Founder and CEO Prad Sekar spoke with New Cannabis Ventures about the three divisions of his company and how he sees the medical cannabis industry evolving.
Sekar and his fellow co-founder Kash Qureshi spent years working in the Canadian healthcare space, primarily consulting on practice management strategies for outpatient medical centers. When Canada introduced the Marijuana for Medical Purposes Regulation (MMPR), they saw an opportunity to use data to develop clinical guidelines and establish a foundation of evidence-based data to support safety and efficacy claims.
The Three Divisions of CB2 Insights
Clinical operations. CB2 Insights owns and operates a U.S. network